Target intelligence / Profile preview

Bacterial outer and cytoplasmic membranes

Molecular classification
Other (biological structure, not a protein class), Outer membrane proteins (OMPs), Porins, Lipoproteins
01

Overview

The *bacterial outer membrane* is a unique lipid bilayer present in Gram-negative bacteria, composed primarily of phospholipids in the inner leaflet and lipopolysaccharides in the outer leaflet, with embedded proteins such as porins and lipoproteins that link to the cell wall (peptidoglycan). The *cytoplasmic membrane* (also called the inner membrane) is a phospholipid bilayer that separates the cytoplasm from the periplasmic space and contains inner membrane proteins vital for nutrient transport, energy generation, and cellular signaling. Together, these structures serve as critical physical and functional barriers, contribute to bacterial cell shape and viability, and play essential roles in antibiotic resistance and pathogenesis. The outer membrane especially protects Gram-negative bacteria from hydrophobic antibiotics and environmental threats, while its components, such as lipopolysaccharide, can trigger strong host immune responses[1][2][3][4]. Note: This entry refers to physical membranes, not a distinct molecular therapeutic target, making it non-canonical as a drug target. Drug development typically focuses on membrane-embedded proteins or lipopolysaccharide components, not the membrane structures themselves[1][3][4].

Other names
Outer membrane (OM) and inner membrane (IM) of Gram-negative bacteriabacterial cell envelope
02

Mechanism of action

Membrane disruption (polymyxins break the integrity of the outer membrane); Increased permeability allowing antibiotic entry (e.g., EDTA-mediated LPS removal); Inhibition of membrane protein assembly or function (certain antibiotics target specific OMPs)

03

Biological functions

Permeability barrierCell shape determinationProtection from external environment and antibioticsNutrient uptakeSignal transduction (by embedded proteins)Cell structure and morphology
04

Disease associations

Infection (contributes to intrinsic antibiotic resistance and bacterial virulence)Other (host–pathogen interaction, endotoxic shock via lipopolysaccharide)
05

Safety considerations

Endotoxic shock from lipopolysaccharide release (LPS, especially Lipid A)Unintended damage to host cell membranes if drugs are not selectiveDevelopment of resistance via alterations in membrane composition or permeability barrier
06

Interacting drugs

Polymyxins (bind to and disrupt the outer membrane)

2 more in the full profile.

Beyond the preview

Go deeper on Bacterial outer and cytoplasmic membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial outer and cytoplasmic membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call